According to Frost &; Sullivan (an independent third-party market research institute) reported that the compound annual growth rate of prescription drug market in China is expected to be 20.7% from 2005 to 20 16. Attracted by this rapid growth and huge market demand in China, many overseas pharmaceutical companies are eager to introduce their products into the China market, and some China pharmaceutical companies need to continue to expand their market share in China. According to Frost &; Sullivan, in 2009, the sales of imported prescription drugs in China market increased by 38%, exceeding the growth level of the overall prescription drug sales market in China. Some domestic pharmaceutical companies that lack relevant marketing, promotion and sales capabilities will continue to rely on third-party service providers, such as CMS, to provide such services.
CMS mainly provides marketing, promotion and sales services for affiliated pharmaceutical companies, including paying one-on-one visits to doctors through its own professional marketing team, providing them with professional education in the treatment field related to products, providing clinical education on clinical use, efficacy and side effects of agency products, organizing medical seminars and sponsoring industry conferences. And through its powerful agent marketing and promotion network, it promotes and sells products for domestic pharmaceutical enterprises in China.
CMS services focus on value-creating marketing and promotion services, such as raising product awareness and expanding the number of prescriptions for specific products. CMS also provides other support services for its suppliers to put their products into the China market, including handling the registration procedures of newly imported drugs from China, updating the registration certificate of imported drugs, participating in drug bidding, customs clearance, inspection of imported drugs and other product management matters.